South Africa’s Treatment Action Campaign (TAC) has warned that the country’s HIV treatment program is being threatened by stock shortages of life-saving medicines.
Some 20% of the 2,139 health facilities responding to the largest ever national survey of its kind – conducted by the Stop Stock Outs Project during September and October 2013 – reported antiretroviral (ARV) and/or tuberculosis (TB) medicine stock outs or shortages.
Anele Yawa, TAC national chairman, said: “For people on ART who are forced to interrupt treatment and are left without medicine, this situation is nothing short of a national and provincial crisis, felt on a very personal level. The extent of medicine shortages, especially ARVs, is significant and far beyond previous estimations. In six out of nine provinces over 17% of responding facilities said they were affected.”
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze